242 related articles for article (PubMed ID: 28882457)
1. Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum.
Faust I; Donhauser E; Fischer B; Ibold B; Kuhn J; Knabbe C; Hendig D
Exp Cell Res; 2017 Nov; 360(2):153-162. PubMed ID: 28882457
[TBL] [Abstract][Full Text] [Related]
2. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin counteracts aberrant soft tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6⁻/⁻).
Guo H; Li Q; Chou DW; Uitto J
J Mol Med (Berl); 2013 Oct; 91(10):1177-84. PubMed ID: 23807484
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis.
Hendig D; Langmann T; Kocken S; Zarbock R; Szliska C; Schmitz G; Kleesiek K; Götting C
Lab Invest; 2008 Dec; 88(12):1303-15. PubMed ID: 18936737
[TBL] [Abstract][Full Text] [Related]
5. Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls.
Kuzaj P; Kuhn J; Michalek RD; Karoly ED; Faust I; Dabisch-Ruthe M; Knabbe C; Hendig D
PLoS One; 2014; 9(9):e108336. PubMed ID: 25265166
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of vitamin D and low concentration of transforming growth factor beta 1, a potential role in dermal wound healing.
Ding J; Kwan P; Ma Z; Iwashina T; Wang J; Shankowsky HA; Tredget EE
Burns; 2016 Sep; 42(6):1277-86. PubMed ID: 27222384
[TBL] [Abstract][Full Text] [Related]
7. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients.
Gheduzzi D; Boraldi F; Annovi G; DeVincenzi CP; Schurgers LJ; Vermeer C; Quaglino D; Ronchetti IP
Lab Invest; 2007 Oct; 87(10):998-1008. PubMed ID: 17724449
[TBL] [Abstract][Full Text] [Related]
8. Changes in dermal fibroblasts from Abcc6(-/-) mice are present before and after the onset of ectopic tissue mineralization.
Boraldi F; Bartolomeo A; Li Q; Uitto J; Quaglino D
J Invest Dermatol; 2014 Jul; 134(7):1855-1861. PubMed ID: 24670382
[TBL] [Abstract][Full Text] [Related]
9. Pseudoxanthoma elasticum-like papillary dermal elastolysis.
Bagher Zadeh V; Najem N; El-Sayed Hanafy M
Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):35-8. PubMed ID: 21879204
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopic features of pseudoxanthoma elasticum.
Kawashima S; Togawa Y; Miyachi H; Matsue H
Clin Exp Dermatol; 2018 Mar; 43(2):175-179. PubMed ID: 29271496
[TBL] [Abstract][Full Text] [Related]
11. TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation.
Watarai A; Schirmer L; Thönes S; Freudenberg U; Werner C; Simon JC; Anderegg U
Acta Biomater; 2015 Oct; 25():65-75. PubMed ID: 26219861
[TBL] [Abstract][Full Text] [Related]
12. Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.
Martin L; Hoppé E; Kauffenstein G; Omarjee L; Navasiolava N; Henni S; Willoteaux S; Leftheriotis G
Bone; 2017 Oct; 103():88-92. PubMed ID: 28658601
[TBL] [Abstract][Full Text] [Related]
13. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro.
Le Saux O; Bunda S; VanWart CM; Douet V; Got L; Martin L; Hinek A
J Invest Dermatol; 2006 Jul; 126(7):1497-505. PubMed ID: 16543900
[TBL] [Abstract][Full Text] [Related]
14. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
Quaglino D; Sartor L; Garbisa S; Boraldi F; Croce A; Passi A; De Luca G; Tiozzo R; Pasquali-Ronchetti I
Biochim Biophys Acta; 2005 Jun; 1741(1-2):42-7. PubMed ID: 15955448
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.
Diekmann U; Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
J Mol Med (Berl); 2009 Oct; 87(10):965-70. PubMed ID: 19575173
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; pseudoxanthoma elasticum and the ABCC6 gene].
Bergen AA; Plomp AS; Gorgels TG; de Jong PT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1586-9. PubMed ID: 15382558
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum.
Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
Clin Chim Acta; 2010 Oct; 411(19-20):1487-90. PubMed ID: 20541540
[TBL] [Abstract][Full Text] [Related]
18. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.
Chassaing N; Martin L; Calvas P; Le Bert M; Hovnanian A
J Med Genet; 2005 Dec; 42(12):881-92. PubMed ID: 15894595
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum.
Hosen MJ; Coucke PJ; Le Saux O; De Paepe A; Vanakker OM
Orphanet J Rare Dis; 2014 Apr; 9():66. PubMed ID: 24775865
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum.
Plümers R; Lindenkamp C; Osterhage MR; Knabbe C; Hendig D
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
